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Acquired hemophilia A is caused by autoantibodies to 
coagulation factor VIII (FVIII). Preoperative diagnosis is 
impaired by the lack of a personal or family history of 
bleeding episodes. Th  erefore, surgical procedures can 
lead to life-threatening hemorrhage [1].
We present a case of a 72-year-old woman who had no 
history of coagulopathy and who was undergoing hys-
tero  scopy and abrasion in a district hospital. Persistent 
vaginal bleeding began immediately after surgery, 
resulting in vaginal hysterectomy on postoperative day 
(POD) 7 and multiple re-laparotomies with intermittent 
abdominal packing between PODs 8 and 37. Acquired 
FVIII deﬁ   ciency was suspected on POD 30, but a 
disseminated intravascular coagulation and treatment 
with various pro-coagulants made the deﬁ  nitive diagnosis 
diﬃ   cult. Bolus applications of recombinant factor VIIa 
(rFVIIa) and von Willebrandt factor-FVIII complex 
between PODs 33 and 38 plus prednisolone pulse therapy 
remained ineﬀ   ective. Acquired FVIII deﬁ  ciency  was 
ﬁ  nally diagnosed upon admission of the intubated and 
ventilated patient to the intensive care unit of a university 
hospital on POD 40. Further FVIII was administered 
because of persistent surgical bleeding. Following 
massive abdominal bleeding on POD 44, the patient 
received FVIII for the next 24 hours and rFVIIa until 
POD 49. On POD 47, the abdominal bleeding ceased.
Th  ree life-threatening airway complications occurred 
under rFVIIa and FVIII therapy. On POD 40, the 
endotracheal tube (ETT) was completely obstructed by 
blood clots. On POD 46, pulmonary gas exchange rapidly 
deteriorated because of a huge thrombus in the left main 
bronchus (2 × 5 cm). On POD 49, a large endobronchial 
thrombus (2 × 7 cm), which was attached to the tip of the 
ETT, was fortunately extracted during the emergency 
removal of the ETT (Figure 1a,b).
Each time, bronchoscopy showed only moderate 
diﬀ  use bleeding from minor mucosal erosions. After the 
critical incident on POD 49, the patient was weaned from 
the respirator and eventually fully recovered.
Intravascular thromboembolic events under treatment 
with rFVIIa and FVIII present a well-known compli-
cation [2,3]. Life-threatening thrombotic airway obstruc-
tions in a mechanically ventilated patient, however, are a 
rare complication. Th   e fact that activated partial thrombo-
plastin times (aPTTs) were spontaneously prolonged (53 
to 66 seconds) and active bleeding was present during 
these events highlights the unpredictable local imbalance 
of pro- and anticoagulant eﬀ  ects during such a treatment. 
In conclusion, intensive care clinicians should be aware 
that minor lacerations of the bronchial mucosa in 
mechanically ventilated patients could lead to blood clots 
and critical airway obstruction under the treatment with 
rFVIIa and FVIII.
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Figure 1. A bronchial thrombus critically obstructed the airways in a long-term ventilated patient under recombinant factor VIIa and 
factor VIII therapy. (a) The thrombus (arrow) was still attached to the tip of the removed endotracheal tube. (b) The detached thrombus (arrow) 
was approximately 20 x 70 mm. With its solid consistency, it occluded the tip of the endotracheal tube and the airways like a cork.
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